ARCHIVES

Gene Therapy Alters Immune Cells For Treatment Of Advanced Melanoma

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

Cetuximab Plus Chemoradiation Boosts Survival in Phase II Study

June 24, 2011

Senate Resolution Urges CMS To Reopen Coverage Policy on ESAs In Oncology.

September 7, 2007

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

In Brief: Gregory Curt Nominated DCT Deputy DCC Seeks Occupational Cancer, Prevention Branch Chiefs

October 26, 1984

Dalton To Head Moffitt Cancer Center; HHS Appoints Gerberding CDC Director

July 12, 2002

Groups Have No Budgets As NCTN Begins Work March 1

February 28, 2014